The gastric mucosa is constantly exposed to conditions that would normally be damaging to living cells. A complex defensive system has evolved that involves multiple mechanisms arranged in a laminar fashion, that as a whole constitute the gastric mucosal barrier to acid. As antisecretory therapy becomes perfected, more attention has been focused on these defensive components of the gastric mucosal barrier in disease. Recently, our laboratory has developed a means of measuring intracellular pH (pHi), mucosal blood flow, acid secretion, surface cell acidification rate, and acid secretion simultaneously in vivo.
Introduction
One of the longest studied mysteries of physiology concerns the question of how the gastric mucosa remains intact and undamaged despite being regularly exposed to amounts of hydrochloric acid which are highly toxic to living cells. Investigations of this question have revealed that a range of defensive mechanisms are present which help mucosal cells to resist acid. A breakdown of these mechanisms would result in an irrevocable fall in surface cell intracellular pH (pHi), cell death, and resultant mucosal injury. It is thus logical that, in the absence of frank injury, the central focus of mucosal defense mech anisms is the maintenance of epithelial cell pHi, which must be preserved despite the enormous H+ gradient between blood and lumen. Surface cells can maintain pHi in the presence of luminal acid by slowing proton entry, which is accomplished by enhancing pre-epithelial factors (mucus gel thickness and bicarbonate secretion), epithelial factors (proton and bicarbonate exchangers, intercellular tight junctions) or post-epithelial factors (blood flow, vascular bicarbonate delivery, parietal [alka line tide] bicarbonate production during acid secretion). It is likely that all of these factors constantly interact in an integrated, coherent fashion in the normal mucosa so as to preserve surface cell pHi.
In this review, we will discuss the measurement of pHi of gastric epithelial cells as it relates to protection against acid-related injury. We will describe an experimental system that has been developed in our laboratory as a means of evaluating, and of studying the interactions amongst, gastric defense mechanisms. An example of disordered integration of defense mechanisms , cirrhotic gastropathy, will then be described. 
Mechanisms of pHi Regulation in Gastric Epithelial Cells
The concept of acid back-diffusion postulates that luminal acid diffuses through the mucus overlying the gastric epithelium, into the interstitial spaces between cells, and eventually into the epithelial and submucosal cells. By this mechanism, irreversible acidification of the epithelial cells is the first indication of injury to the gastric epithelium, which can then manifest as injury or ulcer. The study of gastric mucosal defense mechanisms has thus either been accomplished by measuring the ability of the mucosa to resist injury, which is complicated by the necessity of using a second agent or perturbation to induce injury, and the inability to control aggressive factors (acid and pepsin). Alternatively, measurement of "barrier function" , namely the ability of the mucosa to resist acidification, is an attractive means of assessing mucosal resistance to acid without the above-noted draw backs of injury studies. Measurement of intramural pH, subepithelial pH, acid back-diffusion, transmucosal po tential difference and pHi in vitro and in vivo have all been used to study barrier function. The following sum marizes some of the current thinking to date (for review, see refs 1 and 2).
Intracellular pH regulation in gastric surface cells
The gastric surface epithelial cell can be described in terms of the paradigm of bicarbonate-secreting cells that are found in the stomach, small intestine, colon, liver, and pancreas.1 These cells secrete vascularly-derived bicarbonate (which in turn arises from systemic metab olism and from parietal cell acid secretion) by an asym metric mechanism involving uptake at the basolateral membrane by a sodium-bicarbonate cotransporter and exit across the apical membrane via a chloride-bicarbonate exchanger. Sodium-proton exchange is additionally pre sent on the basolateral, but not apical membrane. Ar ranged in this fashion, these transporters subserve three important cellular functions: 1) disposal of exogenous protons diffusing into the cells from the interstitial space; 2) excreting excess acid produced as a result of cellular metabolism; and 3) causing the transcellular movement of bicarbonate.3,4 A proton-impermeable apical mem brane and an absence of apical-membrane transport proteins with an affinity for protons protects the cell from acidification due to luminal protons.
The physiological consequences of this arrangement of transporters are twofold. The first is that acidification of surface cells is much easier to achieve from the baso lateral than from the apical pole of the cell.5 This asym metry probably results from the increased permeability and surface area of the basolateral membranes to pro tons.6,7 This enhanced ability to acidify the cells from their basolateral pole has suggested the scheme depicted basolateral bicarbonate. This effect has been demon strated in in vitro studies, in which serosal bicarbonate, but not other buffers, enabled gastric epithelial cells to maintain pH, when exposed to exogenous acid. 4, 5, 8 The same protective effect of vascular bicarbonate has also been demonstrated in ex vivo pouch preparations, where intravenous bicarbonate infusion was correlated with protection from mucosal injury due to hemorrhagic shock and bile acid.9,10 In the absence of exogenous bicarbonate, maintenance of systemic pH by hyperventilation failed to protect against injury. In a dog model of stress gastritis, correction of systemic acidosis was considered more important in the prevention of gastric lesions than was the maintenance of gastric mucosal blood flow." These   Fig 1 Schematic depiction of major acid-base cycles in the gastric epithelium. Acid and base movements through the epithelial cells probably occur as an acid cycle and base cycle. Acid, secreted by the parietal cell by an apical H-K ATPase, is injected into the gastric lumen and back-diffuses through the mucus gel and intercellular tight junctions into the cell interstitium and surface cells. Acid entering the surface cells is removed by a basolateral membrane Na/H exchanger into the interstitial fluid. This excess acid is then removed by the microcirculation. The base cycle consists of bicarbonate being produced by parietal cells as a result of acid secretion. The bicarbonate exits the parietal cells via basolateral Cl/HCO3 exchange into the interstitium, where it is carried by the microcirculation to the base of the surface cells. It then diffuses into the interstitium of the surface cells , where it enters the cells via Na/HCO3 co-transport and exits the cells via an apical membrane Cl/OH (HCO3) exchanger into the mucus gel. In the mucus, it is neutralized by back-diffusing acid to form water and CO2 . (For the sake of simplicity, only known major acid-base pathways are shown).
experiments not only support the role of systemic bicar bonate in the protection of the gastric mucosa, but also are consistent with the strong linkage between mucosal protection and preservation of epithelial cell pHi during acid challenge.
Measurement of pHi in vivo
Measurement of pHi in vitro has been accomplished with the use of fluorescent, trapped intracellular dyes, that work by a pH-dependent shift in the excitation or emission spectra. The same principles apply to in vivo measurement of pHi, which is accomplished by coupling in vivo microscopy to the techniques employed for in vitro pHi measurements. Kaneko and co-workers re ported that they could measure pHi of rat gastric surface cells with the fluorescent dye 5,6 carboxyfluorescein diacetate by superfusing the everted gastric mucosa with dye-containing buffer.12 In this manner, the effects of luminal acid and other factors could be assessed in vivo. An additional benefit of this system was that the thick ness of the overlying gastric mucus gel could be simply measured by alternately focusing on the surface of the adherent mucus, as delineated by carbon particles, and on the fluorescent surface cells. Mucosal blood flow and acid output were also measured in this system, enabling the investigators to assess the function of the pre-epithelial, epithelial, and post-epithelial components of the gastric mucosal barrier in vivo (Fig 2) . The control of luminal pH in this system, regardless of the amount of acid secretion enables study of gastroprotective mechanisms in which aggressive factors are controlled.13,14 Further advantages of the system are the ability to obtain a measure of gel proton permeability, and to observe the interaction of cell acidification with gastric mucosal blood flow.15 Fig 
Enhancement of Gastric Defence Mechanisms by Secretagogues
Since acid is accepted to be the primary agent of gastric injury, it is logical to postulate that gastric defenses are enhanced during stimulation of luminal acid so as to balance defensive capabilities with aggressive factors. Silen's group demonstrated that histamine stimulation of acid secretion by frogs and rabbits increased pHi of gastric mucosal cells, increased intramural pH, and de creased transmural potential difference (a measure of mucosal integrity), suggesting that epithelial defense mechanisms were enhanced by stimulation of acid se cretion. [16] [17] [18] More recent experiments have shown that frog oxynticopeptic and parietal cells are much more resistant to acidification from luminal acid when they are stimulated to secrete.4,19 Recently, Tache and colleagues have shown that the centrally administered thyrotropin releasing hormone (TRH) analog, RX 77368, a vagus nerve-dependent acid secretagogue, is capable of pro tecting the gastric mucosa from damage due to 60% EtOH20 -22 F urther studies with centrally administered 77368 have suggested that gastroprotection is mediated by prostaglandins20-23 and is associated with increased gastric mucosal blood flow.24,25 Gastrin and histamine have been shown to be gastroprotective against experi mental gastric injury. [26] [27] [28] [29] [30] [31] The mechanisms of secretagogue-associated gastro protection have been further explored with in vivo mi croscopy. The synthetic gastrin analog pentagastrin as well as vagal stimulation accomplished with central TRH administration increased mucus gel thickness, and unex pected effect of acid stimulation, suggesting up-regulation of pre-epithelial factors during acid secretion. Both se cretagogues markedly enhanced pHi homeostasis during acid superfusion, manifest as a significantly lower initial acidification rate and as a recovery of pHi towards base line, and were associated with an acid-induced sharp increase in mucosal blood flow. 13 The gastroprotective mechanisms of the secretagogues differed, in that gastro protection associated with vagal (TRH) stimulation was diminished by prostaglandin synthase inhibition with indomethacin, whereas the effects of pentagastrin were not.32 The studies also demonstrated that most of the gastroprotective effects of pentagastrin occur through the release of histamine.13 These studies show that se cretagogues improved pHi homeostasis during luminal acid challenge due to the enhancements of pre-epithelial , epithelial and post-epithelial defense mechanisms , and that prostaglandins and histamine play a significant role in this pHi improvement. Gastric defense mechanisms are thus dynamically regulated according to the acid secretory state of the gastric mucosa, balancing aggressive and defensive factors. Kaunitz 
JD and Tanaka S: Gastric Defenses in vivo
Interaction between Blood Flow, pHi, and Mucus Gel Thickness
In the past few years, the ability to simultaneously measure components of the pre-epithelial, epithelial, and post-epithelial layers of the gastric mucosal barrier in vivo has yielded information on how these components interact in vivo in response to pharmacologic and physio logic manipulations. Two intriguing findings concerns the interaction of blood flow and pHi, and the relation between the initial acidification rate and mucus gel thick ness. The ability to correlate these measurements has indicated that there is an unexpectedly complex inter action between components of the gastric mucosal barrier.
Blood flow and pHi
Nishizaki and co-workers recently discovered that blood flow and pHi were temporally related in that a fall in pHi during luminal acidification triggered a hyperemic response to acid, which in turn was associated with an enhanced recovery in pHi. This phenomenon was observed after treatment with luminally-applied isoproterenol, during pentagastrin infusions, and after treatment with a topical prostaglandin analog.13,14,33 The recovery of pHi with the hyperemic response suggested that this may be one of the means by which enhanced gastric mucosal blood flow prevents gastric injury, and why prevention of the hyperemic response by denervation or other means enhances the susceptibility of the mucosa to injury (Fig 3) . 34.35 Mucus gel thickness, initial acidification rate, and the role of mucus Several studies conducted in vitro have shown that gastric mucus can slow proton diffusion36,37 and can enable the formation of a pH gradient across the muco bicarbonate layer.38,39 The role of mucus in the protection of the gastric mucus, however, has been controversial. Slowing of proton diffusion by mucus does not affect, for example, the amount of protons entering the epithelium over time if luminal proton concentration is held constant. Several recent studies that have been designed to address this issue have yielded data consistent with a protective role of mucus. For instance, simultaneous measurements of intracellular pH and the thickness of the mucus gel overlying gastric surface cells in vivo indicated that sur face cell acidification rates and mucus gel thickness were inversely related. 15 In other words, the thicker the mucus gel, the slower the acidification of the surface cells. Such a relationship is depicted in Fig 4. This relationship is consistent with the hypothesis that proton permeation is slowed by gastric mucus. Other studies indicated that a physico-chemical change of the mucus barrier that slowed proton permeation, produced in the absence of measur able changes in mucosal blood flow, acid secretion, or gel thickness, was associated with protection against injury due to nonsteroidal anti-inflammatory drugs (NSAIDs). These findings, coupled with the thicken Fig ing of the mucus gel associated with secretagogues, strengthened the presumption that the pre-epithelial mucus layer played a major role in protecting the gastric epithelial cells from luminal acid.
Gastric Defense Mechanisms in Cirrhosis
Portal hypertensive gastropathy is a complication of cirrhosis with portal hypertension. The disease is associ ated with a spectrum of gastric lesions, ranging from diffuse erythema, through a reticulated "snake skin" pattern and "cherry-red" spots, to frank hemorrhage. 40, 41 Portal hypertensive gastropathy is the source of hemor rhage in most patients with cirrhosis of the liver with non-variceal upper gastrointestinal bleeding, and com monly complicates sclerotherapy of esophageal varices. 42 The pathogenesis of portal hypertensive gastropathy remains unclear, although increased gastric mucosal blood flow with microvascular congestion and resultant dilation of microvessels and development of vascular ectasias have been implicated. 40, 41 There is little evidence to suggest that aggressive factors such as acid secretion are involved, focusing attention on gastric defensive factors such as the pre-epithelial mucus-bicarbonate layer. 43, 44 There are very few studies that have examined the effect of experimental cirrhosis on pHi regulation in gastric surface cells. Nishizaki and co-workers demon strated that gastric defenses were impaired in carbon tetrachloride (CCl4) induced cirrhosis of the liver, as manifest by spontaneous gastric mucosal lesions, impaired gastric surface cell pHi homeostasis, a thin mucus gel layer, and decreased gastric mucosal blood flow.45 Cir rhosis also impaired the pentagastrin-associated hyper emic response to acid, suggesting damage to the neural mechanisms associated with this response. Cirrhosis thus affects the pre-epithelial and post-epithelial components of the mucosal barrier, impairing the ability of the surface cells to maintain pHi during acid exposure. This impair ment of pHi homeostasis was associated with an enhanced susceptibility to mucosal injury.
Summary and Future Directions
We have shown that the measurement of pHi during luminal acidification is a sensitive early measure of the state of gastric mucosal defense mechanisms. This tech nique, combined with measurement of mucus gel thick ness, acid secretion, and mucosal blood flow, has enabled us to understand how gastric defensive mechanisms inte grate into a coherent, laminar defensive system, that varies according to the presence of luminal acid and the acid-secretory state of the mucosa. Interference with one or more of these mechanisms is associated with pathologic conditions such as cirrhotic gastropathy. On the other hand, pharmacological enhancement of one or more defensive factors can increase the resistance of the gastric mucosa to acid-induced injury.
Recent data has suggested that the two most common entities associated with peptic ulcers, namely H. pylori and NSAIDs produce ulcers by impairing defense mecha nisms rather than by enhancing aggressive factors. 46 Further study of gastric defensive mechanisms should be fruitful for those devising new treatments for these vexing and common problems.
